These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23219523

  • 1. β-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype.
    Wu WJ, Zhang Y, Zeng ZL, Li XB, Hu KS, Luo HY, Yang J, Huang P, Xu RH.
    Biochem Pharmacol; 2013 Feb 15; 85(4):486-96. PubMed ID: 23219523
    [Abstract] [Full Text] [Related]

  • 2. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 15; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 3. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ.
    Anticancer Drugs; 2009 Aug 15; 20(7):559-72. PubMed ID: 19491657
    [Abstract] [Full Text] [Related]

  • 4. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D, Warnecke A, Kalayda GV, Kratz F, Jaehde U.
    J Control Release; 2008 Oct 21; 131(2):100-6. PubMed ID: 18691617
    [Abstract] [Full Text] [Related]

  • 5. Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1.
    Li Q, Zhan M, Chen W, Zhao B, Yang K, Yang J, Yi J, Huang Q, Mohan M, Hou Z, Wang J.
    Oncotarget; 2016 Mar 01; 7(9):10271-82. PubMed ID: 26848531
    [Abstract] [Full Text] [Related]

  • 6. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 7. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G, Kishimoto S, Manorek G, Breaux JK, Howell SB.
    Cancer Chemother Pharmacol; 2007 Feb 15; 59(3):301-12. PubMed ID: 16770583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.
    J Inorg Biochem; 1999 Oct 15; 77(1-2):111-5. PubMed ID: 10626362
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 15; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
    Drewa T, Olszewska-Słonina D, Woźniak A, Styczyński J, Drewa G, Szłyk E, Lakomska I, Kobe J, Czajkowski R.
    Acta Pol Pharm; 2004 Jun 15; 61(1):39-44. PubMed ID: 15259856
    [Abstract] [Full Text] [Related]

  • 17. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
    Zhang Y, Guo G, Ma B, Du R, Xiao H, Yang X, Li W, Gao Y, Li Y, Jing X.
    Anticancer Drugs; 2015 Aug 15; 26(7):698-705. PubMed ID: 25811961
    [Abstract] [Full Text] [Related]

  • 18. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS, Teicher BA, Chan V, Collins LS, Kaufmann ME, Loh C.
    Cancer Res; 1988 May 01; 48(9):2335-41. PubMed ID: 3356001
    [Abstract] [Full Text] [Related]

  • 19. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P, Kalayda GV, Jaehde U, Dulk Hd, Brouwer J, Reedijk J.
    J Inorg Biochem; 2009 May 01; 103(5):791-6. PubMed ID: 19303143
    [Abstract] [Full Text] [Related]

  • 20. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.